Exhibit 10.4


 


SECOND AMENDED AND RESTATED UNIT PRIVATE
PLACEMENT AGREEMENT


 


This Second Amended and Restated Unit Private Placement Agreement (this
“Second Amended and Restated Agreement”) is entered into as of October 14, 2022, by and between Hudson Acquisition
I Corp., a Delaware corporation (the “Company”) and Hudson SPAC Holding LLC, a Delaware limited liability company (the
“Purchaser”). Each of the Company and Purchaser shall be referred to as a “Party” and collectively,
the “Parties”.


 


RECITALS


 


WHEREAS, the Parties entered into certain Amended
and Restated Unit Private Placement Agreement dated February 4, 2022 (the “Amended and Restated Agreement”), pursuant
to which the Purchaser agreed to purchase from the Company on the Closing Date 340,000 Initial Units at $10.00 per Initial Unit in connection
with the Company’s initial public offering (the “IPO”) in the amount of $60,000,000, each Unit consisting of
one share of the Company’s common stock and one right to receive one-tenth (1/10) of a share;


 


WHEREAS, the Parties have determined to change the
terms of the Rights as set forth below;


 


WHEREAS, each Party agrees that the Amended and
Restated Agreement is hereby terminated as of the date hereof, shall be of no further force or effect and completely replaced by this
Second Amended and Restated Agreement;


 


WHEREAS, as a result of such changes, the Parties
desire to enter into this second amended and restated unit private placement agreement.


 


NOW, THEREFORE, in consideration of the promises
and the mutual covenants hereinafter set forth and other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the Company and the Purchaser hereby agree as follows:


 


1. Agreement to Subscribe


 


1.1. Purchase and Issuance of the Initial Units.
For the aggregate sum of $3,400,000 (the “Initial Purchase Price”), upon the terms and subject to the conditions
of this Second Amended and Restated Agreement, the Purchaser hereby agrees to purchase from the Company, and the Company hereby agrees
to sell to the Purchaser, on the Closing Date (as defined in Section 1.2) 340,000 units (the “Initial Units”) at $10.00
per Initial Unit.


 


In addition to the foregoing, the Purchaser hereby
agrees to purchase up to an additional 31,500 Units (“Additional Units” and together with the Initial Units,
the “Units”) at $10.00 per Additional Unit for a purchase price of $315,000 (the “Additional Purchase
Price” and together with the Initial Purchase Price, the “Purchase Price”). The purchase and issuance
of the Additional Units shall occur only in the event that the underwriters’ 45-day over-allotment option (“Over-Allotment
Option”) in the Offering is exercised in full or part. The total number of Additional Units to be purchased hereunder shall
be in the same proportion as the amount of the Over-Allotment Option that is exercised. Each purchase of Additional Units shall occur
simultaneously with the consummation of any portion of the Over-Allotment Option.


 


1.2. Closing. The closing (the “Closing”)
of the Offering shall take place at the offices of Sichenzia Ross Ference LLP, 1185 Avenue of the Americas, 31st Floor, New
York, New York, 10036 simultaneously with the consummation of the Company’s IPO of six million (6,000,000) units. Each unit offered
in this private placement Offering and the Company’s IPO shall consist of one share of common stock of the Company, par value $0.0001
per share (the “Common Shares”), and one right (the “Right”) to receive one-fifth
(1/5) of one Common Share (the “Right Shares”) to be governed by the Rights Agreement (defined herein) and the
consummation of the exercise of all or any portion of the Over-Allotment Option (each a “Closing Date”).


 


1.3. Delivery of the Purchase Price. At least
one business day prior to the effective date of the Company’s registration statement relating to the IPO (“Registration
Statement”), or the date of the exercise of the Over-Allotment Option, if any, the Purchaser agrees to deliver the Initial
Purchase Price or Additional Purchase Price, as the case may be, by certified bank check or wire transfer of immediately available funds
denominated in United States Dollars to an escrow agent to be identified prior to the Closing (“Escrow Agent”), which
is hereby irrevocably authorized to deposit such funds on the applicable Closing Date to the trust account which will be established for
the benefit of the Company’s public shareholders, managed pursuant to that certain Investment Management Trust Agreement to be entered
into by and between the Company and Escrow Agent and into which substantially all of the proceeds of the IPO will be deposited (the “Trust
Account”). If the IPO is not consummated within 14 days of the date the Initial Purchase Price is delivered to Escrow Agent,
the Initial Purchase Price shall be returned to the Purchaser by certified bank check or wire transfer of immediately available funds
denominated in United States Dollars, without interest or deduction.


 






     


     


    

 


1.4. Delivery of Unit Certificate. Upon the
applicable Closing Date after delivery of the Purchase Price in accordance with Section 1.3, the Purchaser shall become irrevocably entitled
to receive a unit certificate representing the Units purchased hereunder.


 


2. Representations and Warranties of the Purchaser


 


The Purchaser represents and warrants to the Company that:


 


2.1. No Government Recommendation or Approval.
It understands that no United States federal or state agency or a similar agency of any other country has passed upon or made any recommendation
or endorsement of the Company, the Offering, the Units, the Rights, the Right Shares, or the Common Shares underlying the Units (excluding
the Right Shares, the “Unit Shares” and, collectively with the Units and the Right Shares, the “Securities”).


 


2.2. Organization. The Purchaser is
a company, validly existing and in good standing under the laws of its jurisdiction and possesses all requisite power and authority necessary
to carry out the transactions contemplated by this Second Amended and Restated Agreement.


 


2.3. Private Offering. It is an “accredited
investor” as such term is defined in Rule 501(a) of Regulation D under the Securities Act of 1933, as amended (the “Securities
Act”). It acknowledges that the sale contemplated hereby is being made in reliance on a private placement exemption to “Accredited
Investors” within the meaning of Section 501(a) of Regulation D under the Securities Act.


 


2.4. Authority. This Second Amended and Restated
Agreement has been validly authorized, executed and delivered by the Purchaser and is a valid and binding agreement enforceable in accordance
with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, fraudulent conveyance or similar laws
affecting the enforcement of creditors’ rights generally and subject to general principles of equity (regardless of whether enforcement
is sought in a proceeding at law or in equity).


 


2.5. No Conflicts. The execution, delivery
and performance of this Second Amended and Restated Agreement and the consummation by the Purchaser of the transactions contemplated hereby
do not violate, conflict with or constitute a default under (i) the Purchaser’s organizational documents, (ii) any agreement, indenture
or instrument to which the Purchaser is a party or (iii) any law, statute, rule or regulation to which the Purchaser is subject, or any
agreement, order, judgment or decree to which the Purchaser is subject.


 


2.6. No Legal Advice from Company.
It acknowledges it has had the opportunity to review this Second Amended and Restated Agreement and the transactions contemplated by this
Second Amended and Restated Agreement and the other agreements entered into between the parties hereto with its own legal counsel and
investment and tax advisors. Except for any statements or representations of the Company made in this Second Amended and Restated Agreement
and the other agreements entered into between the parties hereto, it is relying solely on such counsel and advisors and not on any statements
or representations of the Company or any of its representatives or agents for legal, tax or investment advice with respect to this investment,
the transactions contemplated by this Second Amended and Restated Agreement or the securities laws of any jurisdiction.


 


2.7. Access to Information; Independent Investigation.
Prior to the execution of this Second Amended and Restated Agreement, it has had the opportunity to ask questions of and receive answers
from representatives of the Company concerning an investment in the Company, as well as the finances, operations, business and prospects
of the Company, and the opportunity to obtain additional information to verify the accuracy of all information so obtained. In determining
whether to make this investment, it has relied solely on its own knowledge and understanding of the Company and its business based upon
its own due diligence investigation and the information furnished pursuant to this paragraph. It understands that no person has been authorized
to give any information or to make any representations which were not furnished pursuant to this Section 2 and it has not relied on any
other representations or information in making its investment decision, whether written or oral, relating to the Company, its operations
and/or its prospects.


 






    2


     


    

 


2.8. Reliance on Representations and Warranties.
It understands the Units are being offered and sold to it in reliance on exemptions from the registration requirements under the Securities
Act, and analogous provisions in the laws and regulations of various states, and that the Company is relying upon the truth and accuracy
of the representations, warranties, agreements, acknowledgments and understandings of the Purchaser set forth in this Second Amended and
Restated Agreement in order to determine the applicability of such provisions.


 


2.9. No Advertisements. It is not subscribing
for the Units as a result of or subsequent to any advertisement, article, notice or other communication published in any newspaper, magazine,
or similar media or broadcast over television or radio, or presented at any seminar or meeting.


 


2.10. Legend. It acknowledges and
agrees the certificates evidencing the Units, the Common Shares, the Rights and the Common Shares underlying the Rights shall bear a restrictive
legend (the “Legend”), in form and substance as set forth in Section 4 hereof, prohibiting the offer, sale,
pledge or transfer of the securities, except (i) pursuant to an effective registration statement covering these securities under the Securities
Act or (ii) pursuant to any other exemptions from the registration requirements under the Securities Act and such laws which, in the opinion
of counsel for the Company, is available.


 


2.11. Experience, Financial Capability and Suitability.
It is (i) sophisticated in financial matters and is able to evaluate the risks and benefits of the investment in the Securities and (ii)
able to bear the economic risk of his investment in the Securities for an indefinite period of time because the Securities have not been
registered under the Securities Act and therefore cannot be sold unless subsequently registered under the Securities Act or an exemption
from such registration is available. It has substantial experience in evaluating and investing in transactions of securities in companies
similar to the Company so that it is capable of evaluating the merits and risks of its investment in the Company and has the capacity
to protect its own interests. It has substantial experience in evaluating and investing in transactions of securities in companies similar
to the Company so that it is capable of evaluating the merits and risks of its investment in the Company and has the capacity to protect
its own interests.


 


2.12. Investment Purposes. It is purchasing
the Securities solely for investment purposes, for its own account and not for the account or benefit of any other person, and not with
a view towards the distribution or dissemination thereof and it has no present arrangement to sell the interest in the Securities to or
through any person or entity.


 


2.13. Restrictions on Transfer. It acknowledges
and understands the Units are being offered in a transaction not involving a public offering in the United States within the meaning of
the Securities Act. The Securities have not been registered under the Securities Act, and, if in the future, it decides to offer, resell,
pledge or otherwise transfer the Securities, such Securities may be offered, resold, pledged or otherwise transferred only


 


(A) pursuant to an effective registration statement
filed under the Securities Act,


 


(B) pursuant to an exemption from registration under
Rule 144 promulgated under the Securities Act (“Rule 144”), if available, or


 


(C) pursuant to any other available exemption from
the registration requirements of the Securities Act, and in each case in accordance with any applicable securities laws of any state or
any other jurisdiction. It agrees that if any transfer of its Securities or any interest therein is proposed to be made, as a condition
precedent to any such transfer, it may be required to deliver to the Company an opinion of counsel satisfactory to the Company. Absent
registration or another available exemption from registration, it agrees it will not resell the Securities. It further acknowledges that
because the Company is a shell company, Rule 144 may not be available to it for the resale of the Securities until the one year anniversary
following consummation of the initial Business Combination (defined below) of the Company, despite technical compliance with the requirements
of Rule 144 and the release or waiver of any contractual transfer restrictions.


 






    3


     


    

 


3. Representations and Warranties of the Company


 


The Company represents and warrants to the Purchaser that:


 


3.1. Valid Issuance of Share Capital. The
total number of all classes of share capital which the Company has authority to issue is 200,000,000 shares of common stock. As of the
date hereof, the Company has issued 1,725,000 Common Shares (225,000 shares of which are subjected to forfeiture and none are subject
to redemption as described in the registration statement related to the IPO). All of the issued share capital of the Company has been
duly authorized, validly issued, and are fully paid and non-assessable.


 


3.2. Title to Securities. Upon issuance in
accordance with, and payment pursuant to, the terms hereof, the rights agreement to be entered into with Escrow Agent on or prior to the
closing of the IPO (the “Rights Agreement”), as the case may be, each of the Rights and the Common Shares will
be duly and validly issued, fully paid and non-assessable. On the date of issuance of the Units and the Right Shares shall have been reserved
for issuance. Upon issuance in accordance with the terms hereof and the Rights Agreement, the Purchaser will have or receive good title
to the Right Shares, free and clear of all liens, claims and encumbrances of any kind other than (i) transfer restrictions hereunder and
pursuant to the insider letter to be entered into on or prior to the closing of the IPO (the “Insider Letter”)
and (ii) transfer restrictions under federal and state securities laws.


 


3.3. Organization and Qualification.
The Company has been duly incorporated and is validly existing as a Delaware business company and has the requisite corporate power to
own its properties and assets and to carry on its business as now being conducted.


 


3.4. Authorization; Enforcement. (i) The
Company has the requisite corporate power and authority to enter into and perform its obligations under this Second Amended and Restated
Agreement and to issue the Securities in accordance with the terms hereof, (ii) the execution, delivery and performance of this Second
Amended and Restated Agreement by the Company and the consummation by it of the transactions contemplated hereby have been duly authorized
by all necessary corporate action and no further consent or authorization of the Company or its Board of Directors or shareholders is
required, and (iii) this Second Amended and Restated Agreement constitutes, and upon the execution and delivery thereof, the Rights and
Rights Agreement, will constitute, valid and binding obligations of the Company enforceable against the Company in accordance with their
respective terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, fraudulent conveyance, moratorium,
reorganization, or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by equitable
principles of general application and except as enforcement of rights to indemnity and contribution may be limited by federal and state
securities laws or principles of public policy.


 


3.5 No Conflicts. The execution, delivery
and performance of this Second Amended and Restated Agreement and the consummation by the Company of the transactions contemplated hereby
do not (i) result in a violation of the Company’s bylaws and Certificate of Incorporation, conflict with, or constitute a default
under any agreement, indenture or instrument to which the Company is a party or (iii) conflict with any law, statute, rule or regulation
to which the Company is subject or any agreement, order, judgment or decree to which the Company is subject. Other than any federal, state
or foreign securities filings which may be required to be made by the Company subsequent to the Closing, and any registration statement
which may be filed pursuant thereto, the Company is not required under federal, state or local law, rule or regulation to obtain any consent,
authorization or order of, or make any filing or registration with, any court or governmental agency or self-regulatory entity in order
for it to perform any of its obligations under this Second Amended and Restated Agreement or issue the Units, the Rights or the Common
Shares underlying the Units, Rights in accordance with the terms hereof.


 


4. Legends


 


4.1. Legend. The Company will issue
the Units, the Rights and the Unit Shares, and when issued, the Right Shares purchased by the Purchaser, in the name of the Purchaser.
The Securities will bear the following Legend and appropriate “stop transfer” instructions:


 


THESE SECURITIES (i) HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES
SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND THESE SECURITIES MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE
TRANSFERRED EXCEPT (A) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT FILED UNDER THE SECURITIES ACT, (B) TO A NON-U.S. PERSON IN AN
OFFSHORE TRANSACTION IN ACCORDANCE WITH RULE 903 OR RULE 904 OF REGULATION S UNDER THE SECURITIES ACT, (C) PURSUANT TO THE RESALE LIMITATIONS
SET FORTH IN RULE 905 OF REGULATION S UNDER THE SECURITIES ACT, (D) PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER
THE SECURITIES ACT (IF AVAILABLE) OR (E) PURSUANT TO ANY OTHER EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT, IN
EACH CASE IN ACCORDANCE WITH ANY APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR ANY OTHER JURISDICTION. HEDGING TRANSACTIONS
INVOLVING THESE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT.


 






    4


     


    

 


“THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO
AN AGREEMENT BETWEEN HUDSON ACQUISITION I CORP. AND HUDSON SPAC HOLDING, LLC AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE
DISPOSED DURING THE TERM OF THE LOCKUP PURSUANT TO THE TERMS SET FORTH THEREIN.”


 


4.2. Purchaser’s Compliance. Nothing
in this Section 4 shall affect in any way the Purchaser’s obligations and agreements to comply with all applicable securities laws
upon resale of the Securities.


 


4.3. Company’s Refusal to Register Transfer
of the Securities. The Company shall refuse to register any transfer of the Securities, if in the sole judgment of the Company such
purported transfer would not be made (i) pursuant to an effective registration statement filed under the Securities Act, or (ii) pursuant
to an available exemption from the registration requirements of the Securities Act.


 


4.4. Registration Rights. The Purchaser
will be entitled to certain registration rights which will be governed by a registration rights agreement (“Registration Rights
Agreement”) to be entered into with the Company on or prior to the closing of the IPO.


 


5. Lockup


 


The Purchaser acknowledges and agrees that the Units,
the Rights, the Unit Shares, and the Right Shares shall not be transferable, saleable or assignable until thirty (30) days after the consummation
of an acquisition, share exchange, purchase of all or substantially all of the assets of, or any other similar business combination with
one or more businesses or entities (a “Business Combination”), except to permitted transferees (as defined in
the Insider Letter).


 


6. Securities Laws Restrictions


 


The Purchaser agrees not to sell, transfer, pledge,
hypothecate or otherwise dispose of all or any part of the Securities unless, prior thereto (a) a registration statement on the appropriate
form under the Securities Act and applicable state securities laws with respect to the Securities proposed to be transferred shall then
be effective or (b) the Company shall have received an opinion from counsel reasonably satisfactory to the Company, that such registration
is not required because such transaction complies with the Securities Act and the rules promulgated by the Securities and Exchange Commission
thereunder and with all applicable state securities laws.


 


7. Waiver of Distributions from Trust Account


 


In connection with the Securities purchased pursuant
to this Second Amended and Restated Agreement, the Purchaser hereby waives any and all right, title, interest or claim of any kind in
or to any distributions from the Trust Account.


 


8. Rescission Right Waiver and Indemnification


 


8.1. Rescission Waiver. The Purchaser understands
and acknowledges that an exemption from the registration requirements of the Securities Act requires there be no general solicitation
of purchasers of the Units. In this regard, if the Offering were deemed to be a general solicitation with respect to the Units, the offer
and sale of such Units may not be exempt from registration and, if not, the Purchaser may have a right to rescind its purchase of the
Units. In order to facilitate the completion of the Offering and in order to protect the Company, its shareholders and the Trust Account
from claims that may adversely affect the Company or the interests of its shareholders, the Purchaser hereby agrees to waive, to the maximum
extent permitted by applicable law, any claims, right to sue or rights in law or arbitration, as the case may be, to seek rescission of
its purchase of the Units as a result of the issuance of the Units being deemed to be in violation of Section 5 of the Securities Act.
The Purchaser acknowledges and agrees this waiver is being made in order to induce the Company to sell the Units to the Purchaser. The
Purchaser agrees the foregoing waiver of rescission rights shall apply to any and all known or unknown actions, causes of action, suits,
claims or proceedings (collectively, “Claims”) and related losses, costs, penalties, fees, liabilities and damages,
whether compensatory, consequential or exemplary, and expenses in connection therewith, including reasonable attorneys’ and expert
witness fees and disbursements and all other expenses reasonably incurred in investigating, preparing or defending against any Claims,
whether pending or threatened, in connection with any present or future actual or asserted right to rescind the purchase of the Units
hereunder or relating to the purchase of the Units and the transactions contemplated hereby.


 






    5


     


    

 


8.2. No Recourse Against Trust Account.
The Purchaser agrees not to seek recourse against the Trust Account for any reason whatsoever in connection with its purchase of the Units
or any Claim that may arise now or in the future.


 


8.3. Section 8 Waiver. The Purchaser agrees
that to the extent any waiver of rights under this Section 8 is ineffective as a matter of law, the Purchaser has offered such waiver
for the benefit of the Company as an equitable right that shall survive any statutory disqualification or bar that applies to a legal
right. The Purchaser acknowledges the receipt and sufficiency of the consideration received from the Company hereunder in this regard.


 


9. Terms of the Unit


 


The Units shall be substantially identical to the
Units offered in the IPO as set forth in the Underwriting Agreement, except the Units: (i) will be subject to the transfer restrictions
described herein, and (ii) are being purchased pursuant to an exemption from the registration requirements of the Securities Act and will
become freely tradable only after certain conditions are met or the resale of the Units is registered under the Securities Act.


 


10. Governing Law; Jurisdiction; Waiver
of Jury Trial


 


This Second Amended and Restated Agreement shall
be governed by and construed in accordance with the laws of Delaware for agreements made and to be wholly performed within such territory.
The parties hereto hereby waive any right to a jury trial in connection with any litigation pursuant to this Second Amended and Restated
Agreement and the transactions contemplated hereby.


 


11. Assignment; Entire Agreement; Amendment


 


11.1. Assignment. Neither this Second
Amended and Restated Agreement nor any rights hereunder may be assigned by any party to any other person other than by the Purchaser,
without the prior consent of the Company, to one or more persons agreeing to be bound by the terms hereof. Upon such assignment by a Purchaser,
the assignee(s) shall become Purchaser hereunder and have the rights and obligations provided for herein to the extent of such assignment.


 


11.2. Entire Agreement. This Second
Amended and Restated Agreement sets forth the entire agreement and understanding between the parties as to the subject matter hereof and
supersedes any and all prior discussions, agreements and understandings of any and every nature.


 


11.3. Amendment. Except as expressly provided
in this Second Amended and Restated Agreement, neither this Second Amended and Restated Agreement nor any term hereof may be amended,
waived, discharged or terminated other than by a written instrument signed by the party against whom enforcement of any such amendment,
waiver, discharge or termination is sought.


 


11.4. Binding upon Successors. This
Second Amended and Restated Agreement shall be binding upon and inure to the benefit of the parties hereto and to their respective heirs,
legal representatives, successors and permitted assigns.


 






    6


     


    

 


12. Notices; Indemnity


 


12.1 Notices. All notices, requests, consents
and other communications hereunder shall be in writing, shall be addressed to the receiving party’s address set forth herein or
to such other address as a party may designate by notice hereunder, and shall be either (a) delivered by hand, (b) sent by overnight courier,
or (c) sent by certified mail, return receipt requested, postage prepaid. All notices, requests, consents and other communications hereunder
shall be deemed to have been given either (i) if by hand, at the time of the delivery thereof to the receiving party at the address of
such party set forth above, (ii) if sent by overnight courier, on the next business day following the day such notice is delivered to
the courier service, or (iii) if sent by certified mail, on the fifth business day following the day such mailing is made.


 


12.2 Indemnification. Except as set forth
in Section 8, each party shall indemnify the other party against any loss, cost or damages (including reasonable attorney’s fees
and expenses) incurred as a result of such party’s breach of any representation, warranty, covenant or agreement set forth in this
Second Amended and Restated Agreement.


 


13. Counterparts


 


This Second Amended and Restated Agreement may be
executed in one or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become
effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need
not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or any other form of electronic
delivery, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed)
with the same force and effect as if such signature page were an original thereof.


 


14. Survival; Severability


 


14.1. Survival. The representations, warranties,
covenants and agreements of the parties hereto shall survive the Closing until one (1) year following the consummation of an initial Business
Combination.


 


14.2. Severability. In the event that any
provision of this Second Amended and Restated Agreement becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable
or void, this Second Amended and Restated Agreement shall continue in full force and effect without said provision; provided that no such
severability shall be effective if it materially changes the economic benefit of this Second Amended and Restated Agreement to any party.


 


15. Headings


 


The titles and subtitles used in this Second Amended
and Restated Agreement are used for convenience only and are not to be considered in construing or interpreting this Second Amended and
Restated Agreement.


 


16. Construction


 


The parties hereto have participated jointly in
the negotiation and drafting of this Second Amended and Restated Agreement. If an ambiguity or question of intent or interpretation arises,
this Second Amended and Restated Agreement will be construed as if drafted jointly by the parties hereto and no presumption or burden
of proof will arise favoring or disfavoring any party hereto because of the authorship of any provision of this Second Amended and Restated
Agreement. The words “include,” “includes,” and “including” will be deemed to
be followed by “without limitation.” Pronouns in masculine, feminine, and neuter genders will be construed to include
any other gender, and words in the singular form will be construed to include the plural and vice versa, unless the context otherwise
requires. The words “this Second Amended and Restated Agreement,” “herein,” “hereof,”
“hereby,” “hereunder,” and words of similar import refer to this Second Amended and Restated Agreement
as a whole and not to any particular subdivision unless expressly so limited. The parties hereto intend that each representation, warranty,
and covenant contained herein will have independent significance. If any party hereto has breached any representation, warranty, or covenant
contained herein in any respect, the fact that there exists another representation, warranty or covenant relating to the same subject
matter (regardless of the relative levels of specificity) which such party hereto has not breached will not detract from or mitigate the
fact that such party hereto is in breach of the first representation, warranty, or covenant.


 


[Remainder of page intentionally left blank]


 




    7


     


    

 


This Second Amended and Restated Agreement is accepted by the Company
as of the date first written above.


 


	HUDSON ACQUISITION I CORP.	 
	 	 	 
	By:	/s/ Jiang Hui	 
	Name:  	Jiang Hui	 
	Title:	Chief Executive Officer	 
	 	 	 
	Accepted and agreed this 14th day of October, 2022	 
	 	 	 
	HUDSON SPAC HOLDING, LLC	 
	 	 	 
	By:	/s/ Xiaoyue Zhang	 
	Name:	Xiaoyue Zhang	 
	Title:	Authorized Signatory